< Back

March, 2017

Health Strategies Group Announces the Launch of Global Syndicated Market Research to its Portfolio

For Immediate Release
Date: March 21, 2017 


YARDLEY, P.A., March 21, 2017/PRNewswire/— Health Strategies Group, the leader in market access intelligence and research for pharmaceutical and biotech professionals for over 25 years, along with its partner Visionary Ventures, has announced the global expansion and branding of its syndicated research offerings.

“As the importance and complexity of global market access research has increased for brand, new product, and payer marketers, we found that there was an opportunity to build more sophisticated syndicated research offerings that would provide clients the confidence to move ahead from pipeline to maturity,” stated Rod Cavin, Managing Director, Health Strategies Group. “Health Strategies Group provides an unrivaled network of payers, HTA experts, and key market access stakeholders in the United States, the EU, and select emerging markets, combined with the most innovative approaches that benefit clients, with the right questions asked of the right respondents.”

Now Available: KnowledgeEdge™ HTA Impact on Global Access provides insight on the influence of HTA on access, coverage, and reimbursement so you can anticipate the needs of HTA bodies in key geographies. 

Download the Research Agenda Here. 



For more information about global market access research from Health Strategies Group, visit www.healthstrategies.com/HTAimpact or contact Health Strategies Group at (949) 242-1035 or [email protected].


About Health Strategies Group:
Health Strategies Group offers a dedicated team of research leaders committed to dissecting the trends, identifying customer needs, and pinpointing the barriers and opportunities for pharma within the evolving healthcare environment. Recently, Health Strategies Group was ranked the No. 1 market research company that pharmaceutical and biotech executives would recommend. For more information, visit the company’s website at www.HealthStrategies.com.

About Visionary Ventures:
Visionary Ventures develops value propositions, pricing, and market access strategies across cost containment and reimbursement models, products, medical conditions, and care settings. Visionary Ventures delivers a formulated global market access strategy and has launched and negotiated pricing and reimbursement for 15 new drugs since 2009 on the global and multiregional levels. Visionary Ventures is led by industry veterans Sanjay Shah and Peter Lauper, PhD. For more information, visit the company’s website at www.vvstrat.com.


Want access to more leading research? Click here to request more information.



Please complete the form to have this document sent to your email.


Please complete the form to have this document sent to your email.